Treatment of asymptomatic, mild, and moderate COVID-19 infection

Scientists have found that AYUSH 64 is useful in the treatment of asymptomatic, mild, and moderate COVID-19 infection as an adjunct to standard care.

Daily Current Affairs Quiz 2021

AYUSH 64 is a polyherbal formulation developed by the Central Council for Research in Ayurvedic Sciences. Initially, the drug was developed for Malaria in the year 1980 and now is repurposed for COVID-19.

Ayush Ministry and Council of Scientific and Industrial Research in collaboration have completed a robust multi-center clinical trial to evaluate its safety and efficacy.